HOME > News > Event Recaps > 2023.10.26 Totipro® PE0401 Steals the Spotlight at SSW — Glac Biotech’s Postbiotic Innovation Draws Global Attention
2023.10.26 Totipro® PE0401 Steals the Spotlight at SSW — Glac Biotech’s Postbiotic Innovation Draws Global Attention
Las Vegas has always been a stage for big reveals, but at this year’s SupplySide West (SSW), held October 25–26, the spotlight belonged to Glac Biotech. Among thousands of attendees — from global supplement brands to health industry professionals — Glac unveiled its flagship postbiotic Totipro® PE0401, and the response was overwhelming.
At the booth, visitors crowded in to learn about Glac’s latest science and to taste innovation firsthand. From sleep-support probiotics to the award-winning Totipro® PE0401, the company showed why it has become a global leader in probiotics and postbiotics. Industry leaders didn’t just stop by — they asked how they could bring these ingredients into their own products.
A Sweet Success: Postbiotics in Chocolate
One of the show’s biggest surprises came when Glac showcased PE0401 in an unexpected format — chocolate. Visitors lined up to try it, and the reaction was clear: postbiotics don’t just have to be effective, they can be enjoyable. This sparked conversations with major international ingredient companies about PE0401’s versatility.
Today, the ingredient can be applied across multiple categories:
Beyond Digestion: Postbiotics With Proof
Totipro® PE0401 isn’t just trendy — it’s validated. Backed by functional patents, global patents, and clinical data, the ingredient has proven its ability to regulate the gut and support digestive health. These credentials reassured brand partners that PE0401 can deliver results, no matter which final product format it’s paired with.
Spotlight on Sleep: SA0301 Sleep Probiotic
Another Glac innovation caught global attention at SSW: SA0301, the sleep-support probiotic. With an estimated 200 million people worldwide struggling with insomnia (WHO data), sleep health is now one of the fastest-growing segments in nutrition.
SA0301 was designed to target the gut–brain connection, helping balance neurotransmitter activity through the microbiome. The result: more restful nights, better recovery, and improved overall well-being. For consumers, it’s a natural solution to one of the most common health challenges of modern life.
Looking Ahead: Europe Is Next
SSW was only the beginning. Following its success in Las Vegas, Glac Biotech is now preparing for HI Europe & Fi Europe 2023 in Germany (Nov 28–30). There, the company will spotlight Totipro® PE0401 in whey protein applications, continuing to demonstrate how postbiotics can transform everyday nutrition into advanced health solutions.
For partners looking to lead in innovation, Glac Biotech offers more than ingredients — it offers science, trust, and creativity, ready to power the next generation of global health products.
At the booth, visitors crowded in to learn about Glac’s latest science and to taste innovation firsthand. From sleep-support probiotics to the award-winning Totipro® PE0401, the company showed why it has become a global leader in probiotics and postbiotics. Industry leaders didn’t just stop by — they asked how they could bring these ingredients into their own products.
A Sweet Success: Postbiotics in Chocolate
One of the show’s biggest surprises came when Glac showcased PE0401 in an unexpected format — chocolate. Visitors lined up to try it, and the reaction was clear: postbiotics don’t just have to be effective, they can be enjoyable. This sparked conversations with major international ingredient companies about PE0401’s versatility.
Today, the ingredient can be applied across multiple categories:
- Functional chocolates
- Whey protein products
- Gummies and candies
Beyond Digestion: Postbiotics With Proof
Totipro® PE0401 isn’t just trendy — it’s validated. Backed by functional patents, global patents, and clinical data, the ingredient has proven its ability to regulate the gut and support digestive health. These credentials reassured brand partners that PE0401 can deliver results, no matter which final product format it’s paired with.
Spotlight on Sleep: SA0301 Sleep Probiotic
Another Glac innovation caught global attention at SSW: SA0301, the sleep-support probiotic. With an estimated 200 million people worldwide struggling with insomnia (WHO data), sleep health is now one of the fastest-growing segments in nutrition.
SA0301 was designed to target the gut–brain connection, helping balance neurotransmitter activity through the microbiome. The result: more restful nights, better recovery, and improved overall well-being. For consumers, it’s a natural solution to one of the most common health challenges of modern life.
Looking Ahead: Europe Is Next
SSW was only the beginning. Following its success in Las Vegas, Glac Biotech is now preparing for HI Europe & Fi Europe 2023 in Germany (Nov 28–30). There, the company will spotlight Totipro® PE0401 in whey protein applications, continuing to demonstrate how postbiotics can transform everyday nutrition into advanced health solutions.
For partners looking to lead in innovation, Glac Biotech offers more than ingredients — it offers science, trust, and creativity, ready to power the next generation of global health products.
-
2023.2.3 Spring Banquet Celebration — Glac Biotech’s 2023 Performance Soars
-
2024.05.22 Brain Health Innovation Draws Global Attention — Glac Biotech Shines at Vitafoods Europe
-
2023.09.30 Glac Sparks Global Buzz at Vitafoods Asia — Women’s Probiotics and Totipro® Postbiotics Take Center Stage
-
2023.7.31 Glac Biotech Shines at BioAsia Taiwan — Probiotic Innovations Spark Global Collaboration